These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 21659626

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
    Vaidyanathan S, Valencia J, Kemp C, Zhao C, Yeh CM, Bizot MN, Denouel J, Dieterich HA, Dole WP.
    Int J Clin Pract; 2006 Nov; 60(11):1343-56. PubMed ID: 17073832
    [Abstract] [Full Text] [Related]

  • 3. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
    Villamil A, Chrysant SG, Calhoun D, Schober B, Hsu H, Matrisciano-Dimichino L, Zhang J.
    J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
    [Abstract] [Full Text] [Related]

  • 4. Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide.
    Schmieder RE, Philipp T, Guerediaga J, Gorostidi M, Smith B, Weissbach N, Maboudian M, Botha J, van Ingen H.
    Circulation; 2009 Jan 27; 119(3):417-25. PubMed ID: 19139391
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of aliskiren 300  mg/hydrochlorothiazide 25  mg (± amlodipine 5  mg) in hypertensive patients not controlled by candesartan 32  mg plus HCT 25  mg.
    Schweizer J, Ulmer HJ, Benduhn H, Klebs S.
    Curr Med Res Opin; 2011 Jan 27; 27(1):131-40. PubMed ID: 21117946
    [Abstract] [Full Text] [Related]

  • 9. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
    Pool JL, Schmieder RE, Azizi M, Aldigier JC, Januszewicz A, Zidek W, Chiang Y, Satlin A.
    Am J Hypertens; 2007 Jan 27; 20(1):11-20. PubMed ID: 17198906
    [Abstract] [Full Text] [Related]

  • 10. The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.
    Gradman AH, Traub D.
    Rev Cardiovasc Med; 2007 Jan 27; 8 Suppl 2():S22-30. PubMed ID: 17401313
    [Abstract] [Full Text] [Related]

  • 11. The single pill triple combination of aliskiren, amlodipine, and hydrochlorothiazide in the treatment of hypertension.
    Huan Y, Townsend R.
    Expert Opin Pharmacother; 2012 Nov 27; 13(16):2409-15. PubMed ID: 23067322
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of the dose--response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension.
    Puig JG, Schunkert H, Taylor AA, Boye S, Jin J, Keefe DL.
    Clin Ther; 2009 Dec 27; 31(12):2839-50. PubMed ID: 20110023
    [Abstract] [Full Text] [Related]

  • 15. Aliskiren-hydrochlorothiazide combination for the treatment of hypertension.
    Chrysant SG.
    Expert Rev Cardiovasc Ther; 2008 Mar 27; 6(3):305-14. PubMed ID: 18327992
    [Abstract] [Full Text] [Related]

  • 16. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
    Dietz R, Dechend R, Yu CM, Bheda M, Ford J, Prescott MF, Keefe DL.
    J Renin Angiotensin Aldosterone Syst; 2008 Sep 27; 9(3):163-75. PubMed ID: 18957387
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term safety, tolerability, and antihypertensive efficacy of aliskiren, an oral direct renin inhibitor, in Japanese patients with hypertension.
    Kushiro T, Itakura H, Abo Y, Gotou H, Terao S, Keefe DL.
    Hypertens Res; 2009 Mar 27; 32(3):169-75. PubMed ID: 19262478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.